Search research articles
Contact Us
Filters
Showing results (41-50 of 253) with videos related to
Page
of 26
Sort By:
Drug Design, Development and Therapy
|
June 18, 2021
The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease
Giovanni Abbruzzese, Paolo Barone, Leonardo Lopiano, et al.
Nature Reviews. Neurology
|
November 4, 2024
Parkinson disease therapy: current strategies and future research priorities
Fabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
November 28, 2018
Pharmacokinetic drug evaluation of CVT-301 for the treatment of Parkinson's disease
Fabrizio Stocchi, Laura Vacca, Paola Stirpe, et al.
Expert Opinion on Pharmacotherapy
|
February 25, 2021
An evaluation of the efficacy and value of CVT-301 for the treatment of Parkinson's disease
Fabrizio Stocchi, Laura Vacca, Andrea Grassi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 8, 2013
The vatican meeting on neuroprotection for Parkinson's disease
C Warren Olanow, Jose A Obeso, Fabrizio Stocchi
Brain : a Journal of Neurology
|
August 17, 2002
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
Fabrizio Stocchi, Stefano Ruggieri, Laura Vacca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 17, 2025
Obituary for C. Warren Olanow
José A Obeso, Anthony H V Schapira, Fabrizio Stocchi
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 7, 2021
On-Demand Therapy for OFF Episodes in Parkinson's Disease
C Warren Olanow, Werner Poewe, Olivier Rascol, et al.
Archives of Neurology
|
June 16, 2005
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study
Fabrizio Stocchi, Laura Vacca, Stefano Ruggieri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2011
PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease
Fabrizio Stocchi, Luigi Giorgi, Brian Hunter, et al.
Page
of 26
Search research articles
Search
Showing results (41-50 of 253) with videos related to
Sort By:
Page
of 26
Drug Design, Development and Therapy
|
June 18, 2021
The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease
Giovanni Abbruzzese, Paolo Barone, Leonardo Lopiano, et al.
Nature Reviews. Neurology
|
November 4, 2024
Parkinson disease therapy: current strategies and future research priorities
Fabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
November 28, 2018
Pharmacokinetic drug evaluation of CVT-301 for the treatment of Parkinson's disease
Fabrizio Stocchi, Laura Vacca, Paola Stirpe, et al.
Expert Opinion on Pharmacotherapy
|
February 25, 2021
An evaluation of the efficacy and value of CVT-301 for the treatment of Parkinson's disease
Fabrizio Stocchi, Laura Vacca, Andrea Grassi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 8, 2013
The vatican meeting on neuroprotection for Parkinson's disease
C Warren Olanow, Jose A Obeso, Fabrizio Stocchi
Brain : a Journal of Neurology
|
August 17, 2002
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
Fabrizio Stocchi, Stefano Ruggieri, Laura Vacca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 17, 2025
Obituary for C. Warren Olanow
José A Obeso, Anthony H V Schapira, Fabrizio Stocchi
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 7, 2021
On-Demand Therapy for OFF Episodes in Parkinson's Disease
C Warren Olanow, Werner Poewe, Olivier Rascol, et al.
Archives of Neurology
|
June 16, 2005
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study
Fabrizio Stocchi, Laura Vacca, Stefano Ruggieri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2011
PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease
Fabrizio Stocchi, Luigi Giorgi, Brian Hunter, et al.
Page
of 26